APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ziprasidone

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Ziprasidone Market Analysis and Forecast 2026-2032

20 December 2025198 pages

Choose your research edition.

Industry ResearchZiprasidone Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Ziprasidone Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Ziprasidone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ziprasidone Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Ziprasidone Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Ziprasidone market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Ziprasidone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Ziprasidone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Ziprasidone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Ziprasidone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Ziprasidone include Apotex, Aurobindo, Dr. Reddy's Laboratories, Lupin Pharmaceuticals, Macleods Pharmaceuticals, Wockhardt, Zydus Pharmaceuticals, Pfizer and Mylan Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Ziprasidone, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Ziprasidone, also provides the sales of main regions and countries. Of the upcoming market potential for Ziprasidone, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Ziprasidone sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Ziprasidone market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Ziprasidone sales, projected growth trends, production technology, application and end-user industry.

Ziprasidone Segment by Company

Apotex

Aurobindo

Dr. Reddy's Laboratories

Lupin Pharmaceuticals

Macleods Pharmaceuticals

Wockhardt

Zydus Pharmaceuticals

Pfizer

Mylan Pharmaceuticals

Sandoz

Ziprasidone Segment by Type

Oral Capsule

Injection

Ziprasidone Segment by Application

Hospital

Drug Store

Ziprasidone Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ziprasidone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ziprasidone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ziprasidone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Ziprasidone in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Ziprasidone manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ziprasidone sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Ziprasidone Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Oral Capsule Major Manufacturers Table 3. Injection Major Manufacturers Table 4. Global Ziprasidone Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Drug Store Major Manufacturers Table 7. Ziprasidone Industry Trends Table 8. Ziprasidone Industry Drivers Table 9. Ziprasidone Industry Opportunities and Challenges Table 10. Ziprasidone Industry Restraints Table 11. Global Ziprasidone Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Ziprasidone Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Ziprasidone Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Ziprasidone Revenue Market Share by Region (2021-2026) Table 15. Global Ziprasidone Revenue Market Share by Region (2027-2032) Table 16. Global Ziprasidone Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 17. Global Ziprasidone Sales by Region (2021-2026) & (W Units) Table 18. Global Ziprasidone Sales by Region (2027-2032) & (W Units) Table 19. Global Ziprasidone Sales Market Share by Region (2021-2026) Table 20. Global Ziprasidone Sales Market Share by Region (2027-2032) Table 21. Global Ziprasidone Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Ziprasidone Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Ziprasidone Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Ziprasidone Sales Market Share by Manufacturers (2021-2026) Table 25. Global Ziprasidone Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Ziprasidone Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Ziprasidone Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Ziprasidone Manufacturers, Product Type & Application Table 29. Global Ziprasidone Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Ziprasidone by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Ziprasidone Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Ziprasidone Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Ziprasidone Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Ziprasidone Revenue Market Share by Type (2021-2026) Table 36. Global Ziprasidone Revenue Market Share by Type (2027-2032) Table 37. Global Ziprasidone Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 38. Global Ziprasidone Sales by Type (2021-2026) & (W Units) Table 39. Global Ziprasidone Sales by Type (2027-2032) & (W Units) Table 40. Global Ziprasidone Sales Market Share by Type (2021-2026) Table 41. Global Ziprasidone Sales Market Share by Type (2027-2032) Table 42. Global Ziprasidone Price by Type (2021-2026) & (US$/Unit) Table 43. Global Ziprasidone Price by Type (2027-2032) & (US$/Unit) Table 44. Global Ziprasidone Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Ziprasidone Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Ziprasidone Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Ziprasidone Revenue Market Share by Application (2021-2026) Table 48. Global Ziprasidone Revenue Market Share by Application (2027-2032) Table 49. Global Ziprasidone Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 50. Global Ziprasidone Sales by Application (2021-2026) & (W Units) Table 51. Global Ziprasidone Sales by Application (2027-2032) & (W Units) Table 52. Global Ziprasidone Sales Market Share by Application (2021-2026) Table 53. Global Ziprasidone Sales Market Share by Application (2027-2032) Table 54. Global Ziprasidone Price by Application (2021-2026) & (US$/Unit) Table 55. Global Ziprasidone Price by Application (2027-2032) & (US$/Unit) Table 56. Apotex Company Information Table 57. Apotex Business Overview Table 58. Apotex Ziprasidone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. Apotex Ziprasidone Product Portfolio Table 60. Apotex Recent Development Table 61. Aurobindo Company Information Table 62. Aurobindo Business Overview Table 63. Aurobindo Ziprasidone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Aurobindo Ziprasidone Product Portfolio Table 65. Aurobindo Recent Development Table 66. Dr. Reddy's Laboratories Company Information Table 67. Dr. Reddy's Laboratories Business Overview Table 68. Dr. Reddy's Laboratories Ziprasidone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Dr. Reddy's Laboratories Ziprasidone Product Portfolio Table 70. Dr. Reddy's Laboratories Recent Development Table 71. Lupin Pharmaceuticals Company Information Table 72. Lupin Pharmaceuticals Business Overview Table 73. Lupin Pharmaceuticals Ziprasidone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Lupin Pharmaceuticals Ziprasidone Product Portfolio Table 75. Lupin Pharmaceuticals Recent Development Table 76. Macleods Pharmaceuticals Company Information Table 77. Macleods Pharmaceuticals Business Overview Table 78. Macleods Pharmaceuticals Ziprasidone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Macleods Pharmaceuticals Ziprasidone Product Portfolio Table 80. Macleods Pharmaceuticals Recent Development Table 81. Wockhardt Company Information Table 82. Wockhardt Business Overview Table 83. Wockhardt Ziprasidone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Wockhardt Ziprasidone Product Portfolio Table 85. Wockhardt Recent Development Table 86. Zydus Pharmaceuticals Company Information Table 87. Zydus Pharmaceuticals Business Overview Table 88. Zydus Pharmaceuticals Ziprasidone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Zydus Pharmaceuticals Ziprasidone Product Portfolio Table 90. Zydus Pharmaceuticals Recent Development Table 91. Pfizer Company Information Table 92. Pfizer Business Overview Table 93. Pfizer Ziprasidone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Pfizer Ziprasidone Product Portfolio Table 95. Pfizer Recent Development Table 96. Mylan Pharmaceuticals Company Information Table 97. Mylan Pharmaceuticals Business Overview Table 98. Mylan Pharmaceuticals Ziprasidone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Mylan Pharmaceuticals Ziprasidone Product Portfolio Table 100. Mylan Pharmaceuticals Recent Development Table 101. Sandoz Company Information Table 102. Sandoz Business Overview Table 103. Sandoz Ziprasidone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Sandoz Ziprasidone Product Portfolio Table 105. Sandoz Recent Development Table 106. North America Ziprasidone Revenue by Type (2021-2026) & (US$ Million) Table 107. North America Ziprasidone Revenue by Type (2027-2032) & (US$ Million) Table 108. North America Ziprasidone Sales by Type (2021-2026) & (W Units) Table 109. North America Ziprasidone Sales by Type (2027-2032) & (W Units) Table 110. North America Ziprasidone Sales Price by Type (2021-2026) & (US$/Unit) Table 111. North America Ziprasidone Sales Price by Type (2027-2032) & (US$/Unit) Table 112. North America Ziprasidone Revenue by Application (2021-2026) & (US$ Million) Table 113. North America Ziprasidone Revenue by Application (2027-2032) & (US$ Million) Table 114. North America Ziprasidone Sales by Application (2021-2026) & (W Units) Table 115. North America Ziprasidone Sales by Application (2027-2032) & (W Units) Table 116. North America Ziprasidone Sales Price by Application (2021-2026) & (US$/Unit) Table 117. North America Ziprasidone Sales Price by Application (2027-2032) & (US$/Unit) Table 118. North America Ziprasidone Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. North America Ziprasidone Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 120. North America Ziprasidone Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 121. North America Ziprasidone Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 122. North America Ziprasidone Sales by Country (2021-2026) & (W Units) Table 123. North America Ziprasidone Sales by Country (2027-2032) & (W Units) Table 124. North America Ziprasidone Sales Price by Country (2021-2026) & (US$/Unit) Table 125. North America Ziprasidone Sales Price by Country (2027-2032) & (US$/Unit) Table 126. United States Ziprasidone Revenue (2021-2032) & (US$ Million) Table 127. Canada Ziprasidone Revenue (2021-2032) & (US$ Million) Table 128. Europe Ziprasidone Revenue by Type (2021-2026) & (US$ Million) Table 129. Europe Ziprasidone Revenue by Type (2027-2032) & (US$ Million) Table 130. Europe Ziprasidone Sales by Type (2021-2026) & (W Units) Table 131. Europe Ziprasidone Sales by Type (2027-2032) & (W Units) Table 132. Europe Ziprasidone Sales Price by Type (2021-2026) & (US$/Unit) Table 133. Europe Ziprasidone Sales Price by Type (2027-2032) & (US$/Unit) Table 134. Europe Ziprasidone Revenue by Application (2021-2026) & (US$ Million) Table 135. Europe Ziprasidone Revenue by Application (2027-2032) & (US$ Million) Table 136. Europe Ziprasidone Sales by Application (2021-2026) & (W Units) Table 137. Europe Ziprasidone Sales by Application (2027-2032) & (W Units) Table 138. Europe Ziprasidone Sales Price by Application (2021-2026) & (US$/Unit) Table 139. Europe Ziprasidone Sales Price by Application (2027-2032) & (US$/Unit) Table 140. Europe Ziprasidone Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. Europe Ziprasidone Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 142. Europe Ziprasidone Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 143. Europe Ziprasidone Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 144. Europe Ziprasidone Sales by Country (2021-2026) & (W Units) Table 145. Europe Ziprasidone Sales by Country (2027-2032) & (W Units) Table 146. Europe Ziprasidone Sales Price by Country (2021-2026) & (US$/Unit) Table 147. Europe Ziprasidone Sales Price by Country (2027-2032) & (US$/Unit) Table 148. Germany Ziprasidone Revenue (2021-2032) & (US$ Million) Table 149. France Ziprasidone Revenue (2021-2032) & (US$ Million) Table 150. U.K. Ziprasidone Revenue (2021-2032) & (US$ Million) Table 151. Italy Ziprasidone Revenue (2021-2032) & (US$ Million) Table 152. Netherlands Ziprasidone Revenue (2021-2032) & (US$ Million) Table 153. China Ziprasidone Revenue by Type (2021-2026) & (US$ Million) Table 154. China Ziprasidone Revenue by Type (2027-2032) & (US$ Million) Table 155. China Ziprasidone Sales by Type (2021-2026) & (W Units) Table 156. China Ziprasidone Sales by Type (2027-2032) & (W Units) Table 157. China Ziprasidone Sales Price by Type (2021-2026) & (US$/Unit) Table 158. China Ziprasidone Sales Price by Type (2027-2032) & (US$/Unit) Table 159. China Ziprasidone Revenue by Application (2021-2026) & (US$ Million) Table 160. China Ziprasidone Revenue by Application (2027-2032) & (US$ Million) Table 161. China Ziprasidone Sales by Application (2021-2026) & (W Units) Table 162. China Ziprasidone Sales by Application (2027-2032) & (W Units) Table 163. China Ziprasidone Sales Price by Application (2021-2026) & (US$/Unit) Table 164. China Ziprasidone Sales Price by Application (2027-2032) & (US$/Unit) Table 165. Asia Ziprasidone Revenue by Type (2021-2026) & (US$ Million) Table 166. Asia Ziprasidone Revenue by Type (2027-2032) & (US$ Million) Table 167. Asia Ziprasidone Sales by Type (2021-2026) & (W Units) Table 168. Asia Ziprasidone Sales by Type (2027-2032) & (W Units) Table 169. Asia Ziprasidone Sales Price by Type (2021-2026) & (US$/Unit) Table 170. Asia Ziprasidone Sales Price by Type (2027-2032) & (US$/Unit) Table 171. Asia Ziprasidone Revenue by Application (2021-2026) & (US$ Million) Table 172. Asia Ziprasidone Revenue by Application (2027-2032) & (US$ Million) Table 173. Asia Ziprasidone Sales by Application (2021-2026) & (W Units) Table 174. Asia Ziprasidone Sales by Application (2027-2032) & (W Units) Table 175. Asia Ziprasidone Sales Price by Application (2021-2026) & (US$/Unit) Table 176. Asia Ziprasidone Sales Price by Application (2027-2032) & (US$/Unit) Table 177. Asia Ziprasidone Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 178. Asia Ziprasidone Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 179. Asia Ziprasidone Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 180. Asia Ziprasidone Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 181. Asia Ziprasidone Sales by Country (2021-2026) & (W Units) Table 182. Asia Ziprasidone Sales by Country (2027-2032) & (W Units) Table 183. Asia Ziprasidone Sales Price by Country (2021-2026) & (US$/Unit) Table 184. Asia Ziprasidone Sales Price by Country (2027-2032) & (US$/Unit) Table 185. Japan Ziprasidone Revenue (2021-2032) & (US$ Million) Table 186. South Korea Ziprasidone Revenue (2021-2032) & (US$ Million) Table 187. India Ziprasidone Revenue (2021-2032) & (US$ Million) Table 188. Australia Ziprasidone Revenue (2021-2032) & (US$ Million) Table 189. China Taiwan Ziprasidone Revenue (2021-2032) & (US$ Million) Table 190. Southeast Asia Ziprasidone Revenue (2021-2032) & (US$ Million) Table 191. SAMEA Ziprasidone Revenue by Type (2021-2026) & (US$ Million) Table 192. SAMEA Ziprasidone Revenue by Type (2027-2032) & (US$ Million) Table 193. SAMEA Ziprasidone Sales by Type (2021-2026) & (W Units) Table 194. SAMEA Ziprasidone Sales by Type (2027-2032) & (W Units) Table 195. SAMEA Ziprasidone Sales Price by Type (2021-2026) & (US$/Unit) Table 196. SAMEA Ziprasidone Sales Price by Type (2027-2032) & (US$/Unit) Table 197. SAMEA Ziprasidone Revenue by Application (2021-2026) & (US$ Million) Table 198. SAMEA Ziprasidone Revenue by Application (2027-2032) & (US$ Million) Table 199. SAMEA Ziprasidone Sales by Application (2021-2026) & (W Units) Table 200. SAMEA Ziprasidone Sales by Application (2027-2032) & (W Units) Table 201. SAMEA Ziprasidone Sales Price by Application (2021-2026) & (US$/Unit) Table 202. SAMEA Ziprasidone Sales Price by Application (2027-2032) & (US$/Unit) Table 203. SAMEA Ziprasidone Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 204. SAMEA Ziprasidone Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 205. SAMEA Ziprasidone Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 206. SAMEA Ziprasidone Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 207. SAMEA Ziprasidone Sales by Country (2021-2026) & (W Units) Table 208. SAMEA Ziprasidone Sales by Country (2027-2032) & (W Units) Table 209. SAMEA Ziprasidone Sales Price by Country (2021-2026) & (US$/Unit) Table 210. SAMEA Ziprasidone Sales Price by Country (2027-2032) & (US$/Unit) Table 211. Brazil Ziprasidone Revenue (2021-2032) & (US$ Million) Table 212. Argentina Ziprasidone Revenue (2021-2032) & (US$ Million) Table 213. Chile Ziprasidone Revenue (2021-2032) & (US$ Million) Table 214. Colombia Ziprasidone Revenue (2021-2032) & (US$ Million) Table 215. Peru Ziprasidone Revenue (2021-2032) & (US$ Million) Table 216. Saudi Arabia Ziprasidone Revenue (2021-2032) & (US$ Million) Table 217. Israel Ziprasidone Revenue (2021-2032) & (US$ Million) Table 218. UAE Ziprasidone Revenue (2021-2032) & (US$ Million) Table 219. Turkey Ziprasidone Revenue (2021-2032) & (US$ Million) Table 220. Iran Ziprasidone Revenue (2021-2032) & (US$ Million) Table 221. Egypt Ziprasidone Revenue (2021-2032) & (US$ Million) Table 222. Key Raw Materials Table 223. Raw Materials Key Suppliers Table 224. Ziprasidone Distributors List Table 225. Ziprasidone Customers List Table 226. Research Programs/Design for This Report Table 227. Authors List of This Report Table 228. Secondary Sources Table 229. Primary Sources List of Figures Figure 1. Ziprasidone Image Figure 2. Global Ziprasidone Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ziprasidone Market Size Share 2021 VS 2025 VS 2032 Figure 4. Oral Capsule Image Figure 5. Injection Image Figure 6. Global Ziprasidone Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Ziprasidone Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Drug Store Image Figure 10. Global Ziprasidone Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Ziprasidone Revenue (2021-2032) & (US$ Million) Figure 12. Global Ziprasidone Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Ziprasidone Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Ziprasidone Revenue Market Share by Region (2021-2032) Figure 15. Global Ziprasidone Sales (2021-2032) & (W Units) Figure 16. Global Ziprasidone Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 17. Global Ziprasidone Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Ziprasidone Sales YoY (2021-2032) & (W Units) Figure 19. Europe Ziprasidone Sales YoY (2021-2032) & (W Units) Figure 20. China Ziprasidone Sales YoY (2021-2032) & (W Units) Figure 21. Asia (Excluding China) Ziprasidone Sales YoY (2021-2032) & (W Units) Figure 22. South America, Middle East and Africa Ziprasidone Sales YoY (2021-2032) & (W Units) Figure 23. Global Ziprasidone Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Ziprasidone Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Ziprasidone Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Ziprasidone Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Ziprasidone Revenue Market Share by Type (2021-2032) Figure 29. Global Ziprasidone Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 30. Global Ziprasidone Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Ziprasidone Sales Market Share by Type (2021-2032) Figure 32. Global Ziprasidone Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Ziprasidone Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Ziprasidone Revenue Market Share by Application (2021-2032) Figure 35. Global Ziprasidone Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 36. Global Ziprasidone Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Ziprasidone Sales Market Share by Application (2021-2032) Figure 38. North America Ziprasidone Revenue Share by Type (2021-2032) Figure 39. North America Ziprasidone Sales Share by Type (2021-2032) Figure 40. North America Ziprasidone Revenue Share by Application (2021-2032) Figure 41. North America Ziprasidone Sales Share by Application (2021-2032) Figure 42. North America Ziprasidone Revenue Share by Country (2021-2032) Figure 43. North America Ziprasidone Sales Share by Country (2021-2032) Figure 44. Europe Ziprasidone Revenue Share by Type (2021-2032) Figure 45. Europe Ziprasidone Sales Share by Type (2021-2032) Figure 46. Europe Ziprasidone Revenue Share by Application (2021-2032) Figure 47. Europe Ziprasidone Sales Share by Application (2021-2032) Figure 48. Europe Ziprasidone Revenue Share by Country (2021-2032) Figure 49. Europe Ziprasidone Sales Share by Country (2021-2032) Figure 50. China Ziprasidone Revenue Share by Type (2021-2032) Figure 51. China Ziprasidone Sales Share by Type (2021-2032) Figure 52. China Ziprasidone Revenue Share by Application (2021-2032) Figure 53. China Ziprasidone Sales Share by Application (2021-2032) Figure 54. Asia Ziprasidone Revenue Share by Type (2021-2032) Figure 55. Asia Ziprasidone Sales Share by Type (2021-2032) Figure 56. Asia Ziprasidone Revenue Share by Application (2021-2032) Figure 57. Asia Ziprasidone Sales Share by Application (2021-2032) Figure 58. Asia Ziprasidone Revenue Share by Country (2021-2032) Figure 59. Asia Ziprasidone Sales Share by Country (2021-2032) Figure 60. SAMEA Ziprasidone Revenue Share by Type (2021-2032) Figure 61. SAMEA Ziprasidone Sales Share by Type (2021-2032) Figure 62. SAMEA Ziprasidone Revenue Share by Application (2021-2032) Figure 63. SAMEA Ziprasidone Sales Share by Application (2021-2032) Figure 64. SAMEA Ziprasidone Revenue Share by Country (2021-2032) Figure 65. SAMEA Ziprasidone Sales Share by Country (2021-2032) Figure 66. Ziprasidone Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Ziprasidone Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Capsule
  • Injection
Applications
  • Hospital
  • Drug Store
Companies covered
  • Apotex
  • Aurobindo
  • Dr. Reddy's Laboratories
  • Lupin Pharmaceuticals
  • Macleods Pharmaceuticals
  • Wockhardt
  • Zydus Pharmaceuticals
  • Pfizer
  • Mylan Pharmaceuticals
  • Sandoz

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Ziprasidone Market by Type
  3. 1.2.1 Global Ziprasidone Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Oral Capsule
  5. 1.2.3 Injection
  6. 1.3 Ziprasidone Market by Application
  7. 1.3.1 Global Ziprasidone Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Drug Store
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Ziprasidone Market Dynamics
  1. 2.1 Ziprasidone Industry Trends
  2. 2.2 Ziprasidone Industry Drivers
  3. 2.3 Ziprasidone Industry Opportunities and Challenges
  4. 2.4 Ziprasidone Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Ziprasidone Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Ziprasidone Revenue by Region
  3. 3.2.1 Global Ziprasidone Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Ziprasidone Revenue by Region (2021-2026)
  5. 3.2.3 Global Ziprasidone Revenue by Region (2027-2032)
  6. 3.2.4 Global Ziprasidone Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Ziprasidone Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Ziprasidone Sales by Region
  9. 3.4.1 Global Ziprasidone Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Ziprasidone Sales by Region (2021-2026)
  11. 3.4.3 Global Ziprasidone Sales by Region (2027-2032)
  12. 3.4.4 Global Ziprasidone Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Ziprasidone Revenue by Manufacturers
  2. 4.1.1 Global Ziprasidone Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Ziprasidone Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Ziprasidone Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Ziprasidone Sales by Manufacturers
  6. 4.2.1 Global Ziprasidone Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Ziprasidone Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Ziprasidone Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Ziprasidone Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Ziprasidone Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Ziprasidone Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Ziprasidone Manufacturers, Product Type & Application
  13. 4.7 Global Ziprasidone Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Ziprasidone Market CR5 and HHI
  16. 4.8.2 2025 Ziprasidone Tier 1, Tier 2, and Tier 3
5 Ziprasidone Market by Type
  1. 5.1 Global Ziprasidone Revenue by Type
  2. 5.1.1 Global Ziprasidone Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Ziprasidone Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Ziprasidone Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Ziprasidone Sales by Type
  6. 5.2.1 Global Ziprasidone Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ziprasidone Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Ziprasidone Sales Market Share by Type (2021-2032)
  9. 5.3 Global Ziprasidone Price by Type
6 Ziprasidone Market by Application
  1. 6.1 Global Ziprasidone Revenue by Application
  2. 6.1.1 Global Ziprasidone Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Ziprasidone Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Ziprasidone Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Ziprasidone Sales by Application
  6. 6.2.1 Global Ziprasidone Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Ziprasidone Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Ziprasidone Sales Market Share by Application (2021-2032)
  9. 6.3 Global Ziprasidone Price by Application
7 Company Profiles
  1. 7.1 Apotex
  2. 7.1.1 Apotex Company Information
  3. 7.1.2 Apotex Business Overview
  4. 7.1.3 Apotex Ziprasidone Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Apotex Ziprasidone Product Portfolio
  6. 7.1.5 Apotex Recent Developments
  7. 7.2 Aurobindo
  8. 7.2.1 Aurobindo Company Information
  9. 7.2.2 Aurobindo Business Overview
  10. 7.2.3 Aurobindo Ziprasidone Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Aurobindo Ziprasidone Product Portfolio
  12. 7.2.5 Aurobindo Recent Developments
  13. 7.3 Dr. Reddy's Laboratories
  14. 7.3.1 Dr. Reddy's Laboratories Company Information
  15. 7.3.2 Dr. Reddy's Laboratories Business Overview
  16. 7.3.3 Dr. Reddy's Laboratories Ziprasidone Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Dr. Reddy's Laboratories Ziprasidone Product Portfolio
  18. 7.3.5 Dr. Reddy's Laboratories Recent Developments
  19. 7.4 Lupin Pharmaceuticals
  20. 7.4.1 Lupin Pharmaceuticals Company Information
  21. 7.4.2 Lupin Pharmaceuticals Business Overview
  22. 7.4.3 Lupin Pharmaceuticals Ziprasidone Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Lupin Pharmaceuticals Ziprasidone Product Portfolio
  24. 7.4.5 Lupin Pharmaceuticals Recent Developments
  25. 7.5 Macleods Pharmaceuticals
  26. 7.5.1 Macleods Pharmaceuticals Company Information
  27. 7.5.2 Macleods Pharmaceuticals Business Overview
  28. 7.5.3 Macleods Pharmaceuticals Ziprasidone Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Macleods Pharmaceuticals Ziprasidone Product Portfolio
  30. 7.5.5 Macleods Pharmaceuticals Recent Developments
  31. 7.6 Wockhardt
  32. 7.6.1 Wockhardt Company Information
  33. 7.6.2 Wockhardt Business Overview
  34. 7.6.3 Wockhardt Ziprasidone Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Wockhardt Ziprasidone Product Portfolio
  36. 7.6.5 Wockhardt Recent Developments
  37. 7.7 Zydus Pharmaceuticals
  38. 7.7.1 Zydus Pharmaceuticals Company Information
  39. 7.7.2 Zydus Pharmaceuticals Business Overview
  40. 7.7.3 Zydus Pharmaceuticals Ziprasidone Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Zydus Pharmaceuticals Ziprasidone Product Portfolio
  42. 7.7.5 Zydus Pharmaceuticals Recent Developments
  43. 7.8 Pfizer
  44. 7.8.1 Pfizer Company Information
  45. 7.8.2 Pfizer Business Overview
  46. 7.8.3 Pfizer Ziprasidone Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Pfizer Ziprasidone Product Portfolio
  48. 7.8.5 Pfizer Recent Developments
  49. 7.9 Mylan Pharmaceuticals
  50. 7.9.1 Mylan Pharmaceuticals Company Information
  51. 7.9.2 Mylan Pharmaceuticals Business Overview
  52. 7.9.3 Mylan Pharmaceuticals Ziprasidone Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Mylan Pharmaceuticals Ziprasidone Product Portfolio
  54. 7.9.5 Mylan Pharmaceuticals Recent Developments
  55. 7.10 Sandoz
  56. 7.10.1 Sandoz Company Information
  57. 7.10.2 Sandoz Business Overview
  58. 7.10.3 Sandoz Ziprasidone Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Sandoz Ziprasidone Product Portfolio
  60. 7.10.5 Sandoz Recent Developments
8 North America
  1. 8.1 North America Ziprasidone Market Size by Type
  2. 8.1.1 North America Ziprasidone Revenue by Type (2021-2032)
  3. 8.1.2 North America Ziprasidone Sales by Type (2021-2032)
  4. 8.1.3 North America Ziprasidone Price by Type (2021-2032)
  5. 8.2 North America Ziprasidone Market Size by Application
  6. 8.2.1 North America Ziprasidone Revenue by Application (2021-2032)
  7. 8.2.2 North America Ziprasidone Sales by Application (2021-2032)
  8. 8.2.3 North America Ziprasidone Price by Application (2021-2032)
  9. 8.3 North America Ziprasidone Market Size by Country
  10. 8.3.1 North America Ziprasidone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Ziprasidone Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Ziprasidone Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Ziprasidone Market Size by Type
  2. 9.1.1 Europe Ziprasidone Revenue by Type (2021-2032)
  3. 9.1.2 Europe Ziprasidone Sales by Type (2021-2032)
  4. 9.1.3 Europe Ziprasidone Price by Type (2021-2032)
  5. 9.2 Europe Ziprasidone Market Size by Application
  6. 9.2.1 Europe Ziprasidone Revenue by Application (2021-2032)
  7. 9.2.2 Europe Ziprasidone Sales by Application (2021-2032)
  8. 9.2.3 Europe Ziprasidone Price by Application (2021-2032)
  9. 9.3 Europe Ziprasidone Market Size by Country
  10. 9.3.1 Europe Ziprasidone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Ziprasidone Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Ziprasidone Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Ziprasidone Market Size by Type
  2. 10.1.1 China Ziprasidone Revenue by Type (2021-2032)
  3. 10.1.2 China Ziprasidone Sales by Type (2021-2032)
  4. 10.1.3 China Ziprasidone Price by Type (2021-2032)
  5. 10.2 China Ziprasidone Market Size by Application
  6. 10.2.1 China Ziprasidone Revenue by Application (2021-2032)
  7. 10.2.2 China Ziprasidone Sales by Application (2021-2032)
  8. 10.2.3 China Ziprasidone Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Ziprasidone Market Size by Type
  2. 11.1.1 Asia Ziprasidone Revenue by Type (2021-2032)
  3. 11.1.2 Asia Ziprasidone Sales by Type (2021-2032)
  4. 11.1.3 Asia Ziprasidone Price by Type (2021-2032)
  5. 11.2 Asia Ziprasidone Market Size by Application
  6. 11.2.1 Asia Ziprasidone Revenue by Application (2021-2032)
  7. 11.2.2 Asia Ziprasidone Sales by Application (2021-2032)
  8. 11.2.3 Asia Ziprasidone Price by Application (2021-2032)
  9. 11.3 Asia Ziprasidone Market Size by Country
  10. 11.3.1 Asia Ziprasidone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Ziprasidone Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Ziprasidone Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Ziprasidone Market Size by Type
  2. 12.1.1 SAMEA Ziprasidone Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Ziprasidone Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Ziprasidone Price by Type (2021-2032)
  5. 12.2 SAMEA Ziprasidone Market Size by Application
  6. 12.2.1 SAMEA Ziprasidone Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Ziprasidone Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Ziprasidone Price by Application (2021-2032)
  9. 12.3 SAMEA Ziprasidone Market Size by Country
  10. 12.3.1 SAMEA Ziprasidone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Ziprasidone Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Ziprasidone Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Ziprasidone Value Chain Analysis
  2. 13.1.1 Ziprasidone Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Ziprasidone Production Mode & Process
  6. 13.2 Ziprasidone Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Ziprasidone Distributors
  9. 13.2.3 Ziprasidone Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst